These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

4803 related articles for article (PubMed ID: 568919)

  • 41. Combination chemotherapy with DTIC (NSC-45388) in advanced malignant melanoma, soft tissue sarcomas, and Hodgkin's disease.
    Beretta G; Bonadonna G; Bajetta E; Tancini G; De Lena M; Azzarelli A; Veronesi U
    Cancer Treat Rep; 1976 Feb; 60(2):205-11. PubMed ID: 769975
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of scheduling of combinations of 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide and 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea on the Harding-Passey and Cloudman S91 mouse melanomas.
    Hill HZ; Hill GJ
    Cancer Res; 1982 Mar; 42(3):838-42. PubMed ID: 7059982
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The response of hypoxic B16 melanoma cells to in vivo treatment with chemotherapeutic agents.
    Hill RP; Stanley JA
    Cancer Res; 1975 May; 35(5):1147-53. PubMed ID: 1120304
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of the uptake of nucleosides in cultured Harding-Passey melanoma cells by diflubenzuron.
    Mayer RT; Netter KJ; Leising HB; Schachtschabel DO
    Toxicology; 1984 Feb; 30(1):1-6. PubMed ID: 6422584
    [TBL] [Abstract][Full Text] [Related]  

  • 45. P-glycoprotein expression in primary and metastatic malignant melanoma.
    Schadendorf D; Herfordt R; Czarnetzki BM
    Br J Dermatol; 1995 Apr; 132(4):551-5. PubMed ID: 7748745
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chemotherapy of malignant melanoma with dimethyl traizeno imidazole carboxamide (DITC) and nitrosourea derivatives (BCNU, CCNU).
    Hill GJ; Ruess R; Berris R; Philpott GW; Parkin P
    Ann Surg; 1974 Aug; 180(2):167-74. PubMed ID: 4601984
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Small molecule inhibition of polo-like kinase 1 by volasertib (BI 6727) causes significant melanoma growth delay and regression in vivo.
    Cholewa BD; Ndiaye MA; Huang W; Liu X; Ahmad N
    Cancer Lett; 2017 Jan; 385():179-187. PubMed ID: 27793694
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chemosensitivity of human melanoma xenografts in immunocompetent mice and its histological evaluation.
    Dumont P; van der Esch EP; Jabri M; Lejeune F; Atassi G
    Int J Cancer; 1984 Apr; 33(4):447-51. PubMed ID: 6706432
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cisplatin encapsulated in phosphatidylethanolamine liposomes enhances the in vitro cytotoxicity and in vivo intratumor drug accumulation against melanomas.
    Hwang TL; Lee WR; Hua SC; Fang JY
    J Dermatol Sci; 2007 Apr; 46(1):11-20. PubMed ID: 17267180
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preclinical antitumor efficacy of the polyamine analogue N1, N11-diethylnorspermine administered by multiple injection or continuous infusion.
    Bernacki RJ; Oberman EJ; Seweryniak KE; Atwood A; Bergeron RJ; Porter CW
    Clin Cancer Res; 1995 Aug; 1(8):847-57. PubMed ID: 9816054
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adenoviral-mediated herpes simplex virus-thymidine kinase gene transfer in vivo for treatment of experimental human melanoma.
    Bonnekoh B; Greenhalgh DA; Bundman DS; Kosai K; Chen SH; Finegold MJ; Krieg T; Woo SL; Roop R
    J Invest Dermatol; 1996 Jun; 106(6):1163-8. PubMed ID: 8752651
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Drug effects in melanoma: tumor-specific interactions of proflavine and ethidiumbromide.
    Balda BR; Birkmayer GD
    Yale J Biol Med; 1973 Dec; 46(5):464-70. PubMed ID: 4130583
    [No Abstract]   [Full Text] [Related]  

  • 53. Primary cutaneous melanomas seen as inflamed pigmented lesions in patients undergoing adjuvant interferon treatment: a possible diagnostic clue for physicians.
    Hu S; Kim CC; Jessup C; Phung TL; Curiel-Lewandrowski C
    Arch Dermatol; 2009 May; 145(5):565-8. PubMed ID: 19451501
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Casticin Induced Apoptosis in A375.S2 Human Melanoma Cells through the Inhibition of NF-[Formula: see text]B and Mitochondria-Dependent Pathways In Vitro and Inhibited Human Melanoma Xenografts in a Mouse Model In Vivo.
    Shiue YW; Lu CC; Hsiao YP; Liao CL; Lin JP; Lai KC; Yu CC; Huang YP; Ho HC; Chung JG
    Am J Chin Med; 2016; 44(3):637-61. PubMed ID: 27109154
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Activity of thymidine as a chemotherapeutic agent against human tumor xenografts in nude mice.
    Howell SB; Jenkins RS; Streifel J
    Cancer Res; 1979 Oct; 39(10):3875-80. PubMed ID: 476623
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Methylthioadenosine phosphorylase represents a predictive marker for response to adjuvant interferon therapy in patients with malignant melanoma.
    Meyer S; Wild PJ; Vogt T; Bataille F; Ehret C; Gantner S; Landthaler M; Klinkhammer-Schalke M; Hofstaedter F; Bosserhoff AK
    Exp Dermatol; 2010 Aug; 19(8):e251-7. PubMed ID: 20500769
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Chemotherapy of malignant melanoma--current status].
    Karg C; Garbe C; Orfanos CE
    Hautarzt; 1990 Feb; 41(2):56-65. PubMed ID: 2180855
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Enhancing melanoma treatment with resveratrol.
    Osmond GW; Augustine CK; Zipfel PA; Padussis J; Tyler DS
    J Surg Res; 2012 Jan; 172(1):109-15. PubMed ID: 20855085
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sodium-dependent nucleoside transport in the human intestinal brush-border membrane.
    Patil SD; Unadkat JD
    Am J Physiol; 1997 Jun; 272(6 Pt 1):G1314-20. PubMed ID: 9227465
    [TBL] [Abstract][Full Text] [Related]  

  • 60. PARP1 inhibitor olaparib (Lynparza) exerts synthetic lethal effect against ligase 4-deficient melanomas.
    Czyż M; Toma M; Gajos-Michniewicz A; Majchrzak K; Hoser G; Szemraj J; Nieborowska-Skorska M; Cheng P; Gritsyuk D; Levesque M; Dummer R; Sliwinski T; Skorski T
    Oncotarget; 2016 Nov; 7(46):75551-75560. PubMed ID: 27705909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 241.